Summary of the evidence on tadalafil for lower urinary tract symptoms secondary to benign prostate hyperplasia..
Advice on the use of Rezum (NxThera Inc) for treating benign prostatic hyperplasia (BPH) to aid local decision-making
Advice on ADXBLADDER for detecting bladder cancer to aid local decision making
Advice on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume to aid local decision-making
Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making
Advice on the use of Memokath-028, 044 and 045 stents for urethral obstruction and bladder neck or outlet obstructions in men to aid local decision-making
Improving the quality of care for men with lower urinary tract symptoms: shared decision making
Advice on the use of Axonics sacral neuromodulation system (SNM) for overactive bladder and faecal incontinence to aid local decision-making
Advice on the use of the S-Cath System for suprapubic catheterisation to aid local decision-making
This evidence summary has been withdrawn because a product containing oral desmopressin with a marketing authorisation for treating nocturia and nocturnal polyuria in men with lower urinary tract symptom is now available in the UK.